Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00699660 · ClinicalTrials.gov registry record · NA
Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 406
- Enrollment target
NCT00699660: Completed NA study, sponsored by VA Office of Research and Development.
NCT00699660 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 406 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00699660, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 406 participants
- Enrollment target
Study Summary
This project evaluated the impact of semi-structured, standardized interviews on the initial PTSD C\&P on the examination.
Primary Outcome
total completeness of diagnostic assessment score, range from 0 to 100% and completeness of functional assessment
Interventions
- BEHAVIORAL CAPS/WHODAS
- BEHAVIORAL Nonstructured Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT00699660 record still lists
NCT00699660 is an interventional study that assigns participants to a tested intervention. The registered 406 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which CAPS/WHODAS is the first listed.
NCT00699660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00699660 about?
NCT00699660 is a clinical study titled "Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment". This project evaluated the impact of semi-structured, standardized interviews on the initial PTSD C\&P on the examination.
What is the current status of trial NCT00699660?
This trial is currently completed. It is a NA study. The enrollment target is 406 participants. The study started on 2009-05. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00699660?
The interventions under investigation include: CAPS/WHODAS (BEHAVIORAL), Nonstructured Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00699660?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00699660's enrollment target sits among peer trials
406 243rd of 2000 higher than 1,758 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
- NCT06585787 · 406 participants · Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia